Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Following MHRA approval in June 2026 , it is licensed for weight management in the UK alongside diet and physical activity
Nearly half (48.0%) had type 2 diabetes
Individual variation means some achieve more while others achieve less
Stop and Seek Help If Severe allergic reaction (rash, swelling, difficulty breathing) Persistent severe nausea or vomiting not improving with dose reduction Signs of pancreatitis (severe abdominal pain radiating to back) Planned pregnancy or positive pregnancy test Inability to maintain adequate nutrition despite dose adjustments Any concerning symptoms your healthcare provider advises stopping for Always consult your healthcare provider before stopping or modifying your dose
Corsaro, A., Paludi, D., Villa, V., DArrigo, C., Chiovitti, K., Thellung, S., Russo, C., Di Cola, D., Ballerini, P., Patrone, E., Schettini, G., Aceto, A., & Florio, T
Remember that GLP-1 treatment is typically a long-term commitment
US$ 27.92
US$ 23.64
US$ 21.29
